Could cosmo-dermatology be the next big thing in India’s booming skincare and anti-ageing market? It is because consumers are spending more on skincare, hair loss treatments, and aesthetic dermatology procedures. In response, pharmaceutical companies are making substantial investments in this growing sector.
This shift reflects the growing demand for innovative beauty and wellness solutions throughout the country. The rising demand for non-surgical beauty solutions is driving the pharma sector to launch more products and innovations.
Factors driving growth
Several key factors are fuelling the rapid growth of the cosmo-dermatology sector.
- Rising Skin Conditions: Pollution-related skin disorders and diseases such as acne, psoriasis, and dermatitis have greatly increased demand for dermatological treatments.
- Aesthetic Procedures Demand: The growing demand for non-surgical treatments like anti-ageing, hair restoration, and skin rejuvenation is driving pharma companies into cosmo-derma.
- Improved Disposable Incomes: A rise in disposable incomes and a growing middle-class population have enabled more consumers to seek premium skincare and cosmetic dermatology treatments.
A growing industry
The “cosmoderma” segment includes non-surgical treatments that enhance skin appearance. It now makes up 32 per cent of the dermatology market, up from 23 per cent five years ago. Increased consumer awareness of beauty and wellness, along with more wellness centres and beauty clinics, is driving this growth.
Pharma companies entering the market
The leading pharmaceutical firms are recognising the immense potential of the cosmo-dermatology market. In recent months, companies such as Emcure Pharmaceuticals and Glenmark have launched new dermatology-focused subsidiaries and products.
These moves aim to address the growing demand for prescription and consumer skincare products in India. India’s dermatology market has reached Rs 13,860 crore, with an 8 per cent annual growth rate, indicating strong growth potential.
A profitable opportunity beyond price rules
One of the key advantages driving pharma firms to enter the cosmo-dermatology space is the absence of price regulations. Unlike prescription drugs, which are subject to government-set pricing ceilings, cosmo-dermatology products can be launched at flexible price points.
This offers pharmaceutical companies a profitable revenue stream and enables them to adjust prices strategically for maximum profitability.
Maximising future possibilities
As consumer interest in skincare and aesthetic treatments continues to rise, pharmaceutical companies are strategically expanding their presence in the cosmo-dermatology market.
With strong growth projections and a supportive regulatory environment, the sector offers numerous potential for businesses in India’s skincare industry.
Reference link: https://www.news18.com/india/indians-love-for-skincare-anti-ageing-products-boosts-pharma-firms-investment-in-cosmo-dermatology-9129094.html